Telecoaching Plus a Portion Control Device for Weight Management in the Primary Care Setting

February 26, 2015 updated by: Jon Ebbert, Mayo Clinic

Telecoaching Plus a Portion Control Device for Weight Care Management

The purpose of this study was to evaluate the impact of telecoaching conducted by a counselor trained in motivational interviewing paired with a portion control device for obese patients receiving care in a certified patient-centered medical home. The investigators will conduct a randomized, controlled clinical trial evaluating the effectiveness of a telecoaching intervention with a portion control device.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The intervention will be provided during a 3-month period with follow-up through 6 months after randomization. Body mass index (BMI) and waist circumference measurements will be collected at baseline and at 6, 12, 18, and 24 weeks. Participants will also complete measures assessing eating behaviors and physical activity at baseline and at 12 and 24 weeks.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men or women ≥ 18 years and ≤ 55 years of age
  • A BMI of ≥ 30 and ≤ 44.9 kg/m2
  • Motivated to lose weight
  • Able to participate fully in all aspects of the study;
  • Have been provided with, understand, and have signed the informed consent.

Exclusion Criteria:

  • Unstable angina, myocardial infarction, or coronary angioplasty within the past 3 months or an untreated cardiac dysrhythmia
  • A history of a gastric bypass procedure or planned gastric bypass
  • Baseline systolic blood pressure > 180 or diastolic > 100
  • Another member of their household already participating in this study
  • Current treatment with another investigational drug for obesity (within 30 days of study entry)
  • Are pregnant or lactating
  • History of anorexia or bulimia
  • Current binge eating disorder as assessed by the Patient Health Questionnaire eating disorder module (PHQ-ED)
  • Schizophrenia or bipolar disorder or have a PHQ-2 ≥ 337
  • Have been diagnosed with cancer within the past 5 years
  • Are currently participating in a program specifically to lose weight or are on a weight loss medication (last 30 days)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual Care
Behavioral: Usual Care
Subjects were provided with institutional pamphlets on healthy eating and exercise habits
Active Comparator: Telecoaching plus plate
Telecoaching plus portion control plate
Behavioral: Telecoaching plus Plate
A wellness coach proactively contacted the participants every two weeks during treatment, using motivational interviewing. In addition, she provided a portion control plate.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Body Mass Index
Time Frame: Baseline, 3 months and 6 months
Baseline, 3 months and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

February 23, 2015

First Submitted That Met QC Criteria

February 26, 2015

First Posted (Estimate)

February 27, 2015

Study Record Updates

Last Update Posted (Estimate)

February 27, 2015

Last Update Submitted That Met QC Criteria

February 26, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 11001395

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Telecoaching plus Plate

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe